Christina
SVP Acute Cardioversion
Immunology
Acesion Pharma
Denmark
Biography
Christina Sylvest has more than 20 years experience of clinical operations and project management leading global and local Phase I-IV clinical programmes. Prior to joining Acesion, she was responsible for Veloxis Pharmaceuticals A/S (previously Life Cycle Pharma A/S) Phase I-IV clinical operational activities both in Europe and in the US. Prior to that, Christina Sylvest worked in various management roles in clinical development at Rheoscience A/S, Novo Nordisk A/S and Ferring Pharmaceuticals A/S.
Research Interest
Immunology
